Unknown

Dataset Information

PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2.


ABSTRACT:

Background

In the last years, the transmembrane proteoglycan NG2 has gained interest as a therapeutic target for the treatment of diverse tumor types, including gliomas, because increases of its expression correlate with dismal prognosis. NG2 has been shown to function as a co-receptor for PDGF ligands whose aberrant expression is common in gliomas. We have recently generated a glioma model based on the overexpression of PDGF-B in neural progenitors and here we investigated the possible relevance of NG2 during PDGF-driven gliomagenesis.

Methods

The survival curves of NG2-KO mice overexpressing PDGF-B were compared to controls by using a Log-rank test. The characteristics of tumors induced in NG2-KO were compared to those of tumors induced in wild type mice by immunostaining

SUBMITTER: Terrile M 

PROVIDER: S-EPMC2964636 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature